{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T23:08:47Z","timestamp":1785625727305,"version":"3.56.0"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer US","isbn-type":[{"value":"9781071651117","type":"print"},{"value":"9781071651124","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5112-4_10","type":"book-chapter","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T22:47:03Z","timestamp":1785624423000},"page":"153-164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cysteine Re-bridging Using Divinyl Pyrimidine Reagents for the Generation of Antibody-Drug Conjugates"],"prefix":"10.1007","author":[{"given":"Thomas","family":"Wharton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Krajcovicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Spring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrd.2016.268","volume":"16","author":"A Beck","year":"2017","unstructured":"Beck A, Goetsch L, Dumontet C, Corva\u00efa N (2017) Strategies and challenges for the next generation of antibody\u2013drug conjugates. Nat Rev Drug Discov 16:315\u2013337. https:\/\/doi.org\/10.1038\/nrd.2016.268","journal-title":"Nat Rev Drug Discov"},{"key":"10_CR2","doi-asserted-by":"publisher","unstructured":"Riccardi F, Dal Bo M, Macor P, Toffoli G (2023) A comprehensive overview on antibody-drug conjugates: from the conceptualization to cancer therapy. Front Pharmacol 14:1274088. https:\/\/doi.org\/10.3389\/fphar.2023.1274088","DOI":"10.3389\/fphar.2023.1274088"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"D1097","DOI":"10.1093\/nar\/gkad831","volume":"52","author":"L Shen","year":"2024","unstructured":"Shen L, Sun X, Chen Z et al (2024) ADCdb: the database of antibody\u2013drug conjugates. Nucleic Acids Res 52:D1097\u2013D1109. https:\/\/doi.org\/10.1093\/nar\/gkad831","journal-title":"Nucleic Acids Res"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"2229101","DOI":"10.1080\/19420862.2023.2229101","volume":"15","author":"H Maecker","year":"2023","unstructured":"Maecker H, Jonnalagadda V, Bhakta S et al (2023) Exploration of the antibody-drug conjugate clinical landscape. Mabs 15:2229101. https:\/\/doi.org\/10.1080\/19420862.2023.2229101","journal-title":"Mabs"},{"key":"10_CR5","doi-asserted-by":"publisher","unstructured":"Dong W, Wang W, Cao C (2024) The evolution of antibody-drug conjugates: toward accurate DAR and multi-specificity. ChemMedChem 19(17):e202400109. https:\/\/doi.org\/10.1002\/cmdc.202400109","DOI":"10.1002\/cmdc.202400109"},{"key":"10_CR6","doi-asserted-by":"publisher","unstructured":"Hughes B (2010) Antibody\u2013drug conjugates for cancer: poised to deliver? Nat Rev Drug Discov 9:665\u2013667. https:\/\/doi.org\/10.1038\/nrd3270","DOI":"10.1038\/nrd3270"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1158\/1078-0432.CCR-04-0789","volume":"10","author":"KJ Hamblett","year":"2004","unstructured":"Hamblett KJ, Senter PD, Chace DF et al (2004) Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Clin Cancer Res 10:7063\u20137070. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0789","journal-title":"Clin Cancer Res"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"10624","DOI":"10.1039\/C5CC03557K","volume":"51","author":"JPM Nunes","year":"2015","unstructured":"Nunes JPM, Morais M, Vassileva V et al (2015) Functional native disulfide bridging enables delivery of a potent, stable and targeted antibody\u2013drug conjugate (ADC). Chem Commun 51:10624\u201310627. https:\/\/doi.org\/10.1039\/C5CC03557K","journal-title":"Chem Commun"},{"key":"10_CR9","doi-asserted-by":"publisher","unstructured":"Maruani A, Smith MEB, Miranda E et al (2015) A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy. Nat Commun 6:6645. https:\/\/doi.org\/10.1038\/ncomms7645","DOI":"10.1038\/ncomms7645"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"17112","DOI":"10.1002\/chem.201602298","volume":"22","author":"SL Kuan","year":"2016","unstructured":"Kuan SL, Wang T, Weil T (2016) Site-selective disulfide modification of proteins: expanding diversity beyond the proteome. Chem Eur J 22:17112\u201317129","journal-title":"Chem Eur J"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1039\/C8SC04645J","volume":"10","author":"SJ Walsh","year":"2019","unstructured":"Walsh SJ, Omarjee S, Galloway WRJD et al (2019) A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody-drug conjugates. Chem Sci 10:694\u2013700","journal-title":"Chem Sci"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1039\/d0ob00907e","volume":"18","author":"SJ Walsh","year":"2020","unstructured":"Walsh SJ, Iegre J, Seki H et al (2020) General dual functionalisation of biomacromolecules via a cysteine bridging strategy. Org Biomol Chem 18:4224\u20134230.\u2002https:\/\/doi.org\/10.1039\/d0ob00907e","journal-title":"Org Biomol Chem"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1039\/D1CC06766D","volume":"58","author":"SJ Walsh","year":"2022","unstructured":"Walsh SJ, Omarjee S, Dannheim FM et al (2022) Divinylpyrimidine reagents generate antibody\u2013drug conjugates with excellent in vivo efficacy and tolerability. Chem Commun 58:1962\u20131965.\u2002https:\/\/doi.org\/10.1039\/D1CC06766D","journal-title":"Chem Commun"},{"key":"10_CR141","doi-asserted-by":"publisher","unstructured":"Krajcovicova S, Wharton T, Driscoll CL et al (2025) A platform for SpyCatcher conjugation to native antibodies. Chem Sci 16:10602\u201310609. https:\/\/doi.org\/10.1039\/D5SC02286J","DOI":"10.1039\/D5SC02286J"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"8781","DOI":"10.1039\/D2SC02198F","volume":"13","author":"FM Dannheim","year":"2022","unstructured":"Dannheim FM, Walsh SJ, Orozco CT et al (2022) All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading. Chem Sci 13:8781\u20138790. https:\/\/doi.org\/10.1039\/D2SC02198F","journal-title":"Chem Sci"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"9868","DOI":"10.1039\/d3cc02980h","volume":"59","author":"TA King","year":"2023","unstructured":"King TA, Walsh SJ, Kapun M et al (2023) Disulfide re-bridging reagents for single-payload antibody-drug conjugates. Chem Commun\u200259:9868\u20139871.\u2002https:\/\/doi.org\/10.1039\/d3cc02980h","journal-title":"Chem Commun"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"9499","DOI":"10.1039\/C9CC05042F","volume":"55","author":"NS Robertson","year":"2019","unstructured":"Robertson NS, Walsh SJ, Fowler E et al (2019) Macrocyclisation and functionalisation of unprotected peptides: via divinyltriazine cysteine stapling. Chem Commun 55:9499\u20139502","journal-title":"Chem Commun"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"10800","DOI":"10.1039\/D3SC04083F","volume":"14","author":"J Iegre","year":"2023","unstructured":"Iegre J, Krajcovicova S, Gunnarsson A et al (2023) A cell-active cyclic peptide targeting the Nrf2\/Keap1 protein\u2013protein interaction. Chem\u2002Sci\u200214:10800\u201310805.\u2002https:\/\/doi.org\/10.1039\/D3SC04083F","journal-title":"Chem Sci"},{"key":"10_CR18","unstructured":"Expasy ProtParam. https:\/\/web.expasy.org\/protparam\/. Accessed 25 Jan 2025"}],"container-title":["Methods in Molecular Biology","Bioconjugation Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5112-4_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T22:47:05Z","timestamp":1785624425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5112-4_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071651117","9781071651124"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5112-4_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"4 June 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}